Carsten Schwenke
Overview
Explore the profile of Carsten Schwenke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scheller B, Mangner N, Jeger R, Afan S, Mahfoud F, Woitek F, et al.
EuroIntervention
. 2024 Nov;
20(21):e1322-e1329.
PMID: 39492703
Background: Paclitaxel-coated balloons (PCB) are a viable alternative to drug-eluting stents in the treatment of de novo coronary lesions. Whether sirolimus represents an alternative to paclitaxel for drug-coated balloons remains...
2.
Munter K, Lazaro-Martinez J, Kanya S, Sawade L, Schwenke C, Pegalajar-Jurado A, et al.
J Wound Care
. 2024 Oct;
33(10):726-736.
PMID: 39388210
Objective: Delayed or stalled healing in open wounds can result from persisting chronic inflammation related to infection and/or persistent bacterial colonisation and biofilm. Treatment of hard-to-heal wounds focuses on debridement...
3.
Kleinschmidt L, Walendzik A, Wasem J, Hofer K, Nauendorf B, Brittner M, et al.
JMIR Res Protoc
. 2024 Apr;
13:e50932.
PMID: 38602749
Background: Particularly in rural regions, factors such as lower physician density and long travel distances complicate adequate outpatient care. However, urban regions can also be affected by deficits in care,...
4.
Endrikat J, Khater H, Boreham A, Fritze S, Schwenke C, Bhatti A, et al.
Breast Cancer (Auckl)
. 2023 Aug;
17:11782234231189467.
PMID: 37600467
Background: Contrast-enhanced mammography (CEM) is an emerging breast imaging modality. Clinical data is scarce. Objectives: To summarize clinical evidence on the use of iopromide in CEM for the detection or...
5.
Scheller B, Mangner N, S K Abdul Kader M, Wan Ahmad W, Jeger R, Wohrle J, et al.
Circ Cardiovasc Interv
. 2022 Sep;
15(9):e012305.
PMID: 36126132
Background: Paclitaxel-coated balloons (PCBs) are a preferred treatment option for coronary in-stent restenosis. To date, data from randomized trials of alternative drug coatings are lacking. The aim of the randomized...
6.
Puntmann V, Martin S, Shchendrygina A, Hoffmann J, Ka M, Giokoglu E, et al.
Nat Med
. 2022 Sep;
28(10):2117-2123.
PMID: 36064600
Cardiac symptoms are increasingly recognized as late complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in previously well individuals with mild initial illness, but the underlying pathophysiology leading...
7.
Wan Ahmad W, Nuruddin A, S K Abdul Kader M, Ong T, Liew H, Mohd Ali R, et al.
JACC Cardiovasc Interv
. 2022 Mar;
15(7):770-779.
PMID: 35305906
Objectives: The aim of this randomized controlled trial was to investigate a novel sirolimus-coated balloon (SCB) compared with the best investigated paclitaxel-coated balloon (PCB). Background: There is increasing clinical evidence...
8.
Green C, Jost G, Frenzel T, Boyken J, Schwenke C, Pietsch H
Invest Radiol
. 2022 Feb;
57(7):453-462.
PMID: 35125411
Objectives: The aim of the study was to investigate the possible influence of changes in the brain caused by age on relaxometric and relaxation time-weighted magnetic resonance imaging (MRI) parameters...
9.
Zeitlinger M, Bauer M, Reindl-Schwaighofer R, Stoekenbroek R, Lambert G, Berger-Sieczkowski E, et al.
Eur J Clin Pharmacol
. 2021 May;
77(10):1473-1484.
PMID: 33969434
Purpose: AT04A and AT06A are two AFFITOPE® peptide vaccine candidates being developed for the treatment of hypercholesterolemia by inducing proprotein convertase subtilisin/kexin type 9 (PCSK9)-specific antibodies. This study aimed to...
10.
Wright E, Yasmeen N, Malottki K, Sawyer L, Borg E, Schwenke C, et al.
Dermatol Ther (Heidelb)
. 2020 Dec;
11(1):181-220.
PMID: 33351178
Introduction: A range of treatments are available for moderate-to-severe psoriasis; however, there remains a paucity of direct comparisons of these in head-to-head trials. Network meta-analyses (NMA) allow comparisons of these...